BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20537878)

  • 1. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial dose mapping for individualizing radioiodine treatment.
    Lassmann M; Hänscheid H
    J Nucl Med; 2007 Jan; 48(1):2-4. PubMed ID: 17204691
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
    Börner AR; Müller-Gärtner HW
    Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Lam MG; van Isselt JW
    J Nucl Med; 2005 Dec; 46(12):2118; author reply 2118-9. PubMed ID: 16330579
    [No Abstract]   [Full Text] [Related]  

  • 8. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
    De Klerk JM; Oyen WJ
    Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine treatment for differentiated thyroid carcinoma in Japan.
    Okamoto T
    Surgery; 2010 Mar; 147(3):432-3. PubMed ID: 20176244
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.
    Luster M; Hänscheid H; Freudenberg LS; Verburg FA
    J Endocrinol Invest; 2012; 35(6 Suppl):21-9. PubMed ID: 23014070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
    Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Dietlein M; Eschner W; Grünwald F; Lassmann M; Verburg FA; Luster M
    Nuklearmedizin; 2016 Jun; 55(3):77-89. PubMed ID: 27350004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?
    Verburg FA; Luster M; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):183-184. PubMed ID: 27726016
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
    Robbins RJ; Schlumberger MJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.